Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Surgery Today|August 31, 2002
Expression of vascular endothelial growth factor family messenger RNA in diseased thyroid tissuesKatsuhiro Tanaka, Junichi Kurebayashi, Hiroshi Sonoo, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making|April 26, 2021
Randomized Controlled Trial of Paper-Based at a Hospital versus Continual Electronic Patient-Reported Outcomes at Home for Metastatic Cancer Patients: Does Electronic Measurement at Home Detect Patients' Health Status in Greater Detail?Takeru Shiroiwa, Yasuhiro Hagiwara, Naruto Taira, et al.
Surgery Today|September 27, 2003
Metastatic papillary thyroid carcinoma of the submandibular lymph nodes with extensive squamous metaplasia: report of a caseHironori Kunisue, Yoshiki Mikami, Katsuhiro Tanaka, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|July 9, 2015
Joint symptoms and health-related quality of life in postmenopausal women with breast cancer who completed 5 years of anastrozoleHiroshi Yagata, Hiroshi Ohtsu, Yoshifumi Komoike, et al.
Japanese Journal of Clinical Oncology|June 13, 2009
Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgeryShozo Ohsumi, Kojiro Shimozuma, Satoshi Morita, et al.
The Journal of Pediatrics|September 30, 2022
Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in JapanEri Hoshino, Kensuke Moriwaki, Kosuke Morimoto, et al.
Health and Quality of Life Outcomes|January 19, 2024
Perceptions regarding the concept and definition of patient-reported outcomes among healthcare stakeholders in Japan with relation to quality of life: a cross-sectional studyTakako Kaneyasu, Shinya Saito, Kikuko Miyazaki, et al.
Breast Cancer Research and Treatment|June 18, 2011
Associations among baseline variables, treatment-related factors and health-related quality of life 2 years after breast cancer surgeryNaruto Taira, Kojiro Shimozuma, Takeru Shiroiwa, et al.
Pharmacoeconomics|October 19, 2017
Impact of Adverse Events on Health Utility and Health-Related Quality of Life in Patients Receiving First-Line Chemotherapy for Metastatic Breast Cancer: Results from the SELECT BC StudyYasuhiro Hagiwara, Takeru Shiroiwa, Kojiro Shimozuma, et al.
Oncology|November 18, 2017
Patient-Reported Outcome Results from the Open-Label Randomized Phase III SELECT BC Trial Evaluating First-Line S-1 Therapy for Metastatic Breast CancerTakuya Kawahara, Kojiro Shimozuma, Takeru Shiroiwa, et al.
Pageof 9